News und Analysen
EQS-Adhoc: BB Biotech AG publishes its interim report
EQS-News: BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility
Novocure Reports First Quarter 2025 Financial Results
Novocure (NASDAQ: NVCR) today reported financial results for the first quarter ended March 31, 2025. Novocure is a global oncology company working to extend survival in some of the most aggressive
Novocure to Present Results from the Phase 3 PANOVA-3 Clinical Trial of its Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer as a Late-Breaking Oral Presentation at the 2025 ASCO Annual Meeting
Novocure (NASDAQ: NVCR) announced today that it will present additional results from the Phase 3 PANOVA-3 trial of its Tumor Treating Fields (TTFields) therapy for pancreatic cancer at the 2025
Optune Lua® von Novocure erhält CE-Kennzeichnung für die Behandlung von metastasierendem nicht-kleinzelligem Lungenkrebs (mNSCLC)
Novocure (NASDAQ: NVCR) gab heute bekannt, dass Optune Lua® die CE-Kennzeichnung (Conformité Européenne) für die Behandlung von erwachsenen Patienten mit metastasierendem nicht-kleinzelligem
Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
Charles River Laboratories International, Inc. (NYSE: CRL), ahead of the American Association for Cancer Research® (AACR) Annual Meeting in Chicago, IL, has announced updates to its comprehensive
Novocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer
Novocure (NASDAQ: NVCR) announced today that Optune Lua® has received a CE (Conformité Européenne) Mark for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC)
Ecological Threat Report 2025: Extreme Regen- und Trockenperioden werden zunehmend zum Katalysator für schwerwiegende Konflikte
Rund 2 Milliarden Menschen – ein Viertel der Menschheit – leben derzeit in Regionen, die von einem moderaten bis starken Anstieg saisonaler Verschiebungen betroffen sind.
LONDON, UK /
GA-ASI präsentiert mit Flugtests des Collaborative Combat Aircraft YFQ-42A eine weitere Luftfahrtneuheit
San Diego, Kalifornien / ACCESS Newswire / 27. August 2025 / Mit dem Collaborative Combat Aircraft (CCA, kooperatives Kampfflugzeug) YFQ-42A, das von General Atomics Aeronautical Systems,
Magnolia Welcomes Tech Pioneer Luc Haldimann as New Board Chairman to Expand Global Growth and AI Strategy
BASEL, CH / ACCESS Newswire / November 27, 2025 / Magnolia, a leading global Digital Experience Platform (DXP) provider, is excited to announce that renowned software entrepreneur and
